Abiopharma

News list

FDA approves BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE from ASCENT PHARMS INC

FDA Approval
Dec. 31, 2025, 13:45 UTC

Final approval of ANDA #ANDA #219727 for BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE. Decision date: 12/15/2025

Full text

Register to leave comments
There are no comments here yet...